Question

Difficulty: MediumPharmacologic Interventions

A 42-year-old woman is evaluated in the emergency department for severe palpitations, tremulousness, and anxiety that have worsened over the past week. She has a history of severe, persistent asthma that requires multiple hospitalizations each year and daily use of high-dose inhaled budesonide and formoterol. She is diaphoretic and appears anxious. Her temperature is 37.8∘C37.8^\circ\text{C} (100∘F100^\circ\text{F}), blood pressure is 142/78 mmHg142/78\text{ mmHg}, pulse is 122 /min122\text{ /min}, and respirations are 20 /min20\text{ /min}. A fine tremor is noted in her outstretched hands. An electrocardiogram reveals sinus tachycardia at 122 /min122\text{ /min} with no ischemic changes. Laboratory studies show a thyroid-stimulating hormone (TSH) level of <0.01 mIU/L<0.01\text{ mIU/L} and a significantly elevated free T4 level. Which of the following is the most appropriate initial pharmacologic intervention to rapidly control this patient's heart rate?

  1. A
    Intravenous adenosine
  2. B
    Oral propranolol
  3. C
    Oral amiodarone
  4. Oral diltiazemAnswer
  5. E
    Oral propylthiouracil

Answer

Oral diltiazem
Oral diltiazem is the most appropriate initial therapy. In patients with thyrotoxicosis, adrenergic symptoms such as palpitations and tachycardia are typically managed first-line with beta-blockers. However, non-selective beta-blockers (like propranolol) are contraindicated in patients with severe reactive airway disease due to the high risk of severe bronchospasm. In these scenarios, a non-dihydropyridine calcium channel blocker (such as diltiazem or verapamil) is the guideline-recommended alternative to rapidly achieve heart rate control without compromising pulmonary function.

Step-by-Step Solution

1
Diagnose the primary clinical syndrome.
The patient has symptomatic thyrotoxicosis causing severe adrenergic symptoms (tachycardia, tremor, anxiety).
Low TSH, elevated free T4, and clinical presentation confirm a hypermetabolic state requiring prompt symptom management.
2
Determine the standard first-line treatment for the symptoms.
Beta-blockers (e.g., propranolol, atenolol) are the standard first-line therapy to blunt sympathetic hyperactivity in thyrotoxicosis.
They rapidly lower the heart rate and improve neurologic symptoms like tremor.
3
Evaluate the patient for contraindications to the standard therapy.
The patient has a history of severe, persistent asthma.
Non-selective beta-blockers (and even cardioselective ones in severe cases) can trigger life-threatening bronchospasm and are strictly contraindicated.
4
Select the best alternative pharmacologic intervention.
Oral diltiazem is selected.
Non-dihydropyridine calcium channel blockers (diltiazem or verapamil) safely lower the heart rate without causing bronchospasm, making them the guideline-recommended alternative.

Key Concept

Management of thyrotoxicosis adrenergic symptoms with non-dihydropyridine calcium channel blockers when beta-blockers are contraindicated.

Alternative Method

Verapamil is another non-dihydropyridine calcium channel blocker that would be equally acceptable in this scenario if diltiazem was not offered.
Estimated Time:1m 15s
Rate this question